Gadolinium-porphyrins: New potential magnetic resonance imaging contrast agents for melanoma detection

Journal of Research in Medical Sciences

Volumn 11, Issue 4, 2006, Pages 217-223

  Shahbazi Gahrouei, Daryoush ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemotoporphyrin; Melanoma; MRI; Porphyrin based contrast agent

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM CHLORIDE; GADOLINIUM PENTETATE; HEMATOPORPHYRIN DERIVATIVE; PORPHYRIN DERIVATIVE; PROTON; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG RETENTION; DRUG STRUCTURE; DRUG TUMOR LEVEL; HUMAN; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; RELAXATION TIME; TUMOR XENOGRAFT;

EID: 33751036209     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nelson JA, Schmiedl U. Porphyrins as contrast media. Magn Reson Med 1991; 22(2):366-371.
2. Young SW, Sidhu MK, Qing F, Muller HH, Neuder M, Zanassi G et al. Precinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging. Invest Radiol 1994; 29(3):330-338.
3. Ni Y, Petre C, Miao Y, Yu J, Cresens E, Adriaens P et al. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997; 32(12):770-779.
4. Furmanski P, Longley C. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. Cancer Res 1988; 48(16):4604-4610.
5. Ogan MD, Revel D, Brasch RC. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Invest Radiol 1987; 22(10):822-828.
6. Miura M, Micca PL, Fisher CD, Heinrichs JC, Donaldson JA, Finkel GC et al. Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing mice. Int J Cancer 1996; 68(1):114-119.
7. Bourre L, Simonneaux G, Ferrand Y, Thibaut S, Lajat Y, Patrice T. Synthesis, and in vitro and in vivo evaluation of a diphenylchlorin sensitizer for photodynamic therapy. J Photochem Photobiol B 2003; 69(3):179-192.
8. Ferrand Y, Bourre L, Simonneaux G, Thibaut S, Odobel F, Lajat Y et al. Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. Bioorg Med Chem Lett 2003; 13(5):833-835.
9. Shahbazi-Gahrouei D. Development and application of new cancer-specific contrast agents for tumor detection by magnetic resonance imaging. PhD thesis, University of Western Sydney, Australia, 2000.
10. Shahbazi-Gahrouei D, Williams M, Allen BJ. Synthesis and Application of new Gadolinium-Porphyrins as Poterntial MR Imaging Contrast Agents for Cancer Detection in Nude Mice. Iran Biomed J 2001; 5(2-3):87-95.
11. Tamat SR, Moore DE, Allen BJ. Determination of the concentration of complex boronated compounds in biological tissues by inductively coupled plasma atomic emission spectrometry. Pigment Cell Res 1989; 2(4):281-285.
12. Shahbazi-Gahrouei D, Williams M, Allen BJ. In vitro study of relationship between signal intensity and gadolinium-DTPA concentration at high magnetic field strength. Australas Radiol 2001; 45(3):298-304.
13. Lyon RC, Faustino PJ, Cohen JS, Katz A, Mornex F, Colcher D et al. Tissue distribution and stability of metalloporphyrin MRI contrast agents. Magn Reson Med 1987; 4(1):24-33.
14. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys 1984; 11(4):425-448.
15. Hindre F, Le Plouzennec M, de Certaines JD, Foultier MT, Patrice T, Simonneaux G. Tetra-p-aminophenylporphyrin conjugated with Gd-DTPA: tumor-specific contrast agent for MR imaging. J Magn Reson Imaging 1993; 3(1):59-65.